Skip to main content

Dynavax Technologies Corporation (DVAX)

NASDAQ: DVAX · IEX Real-Time Price · USD
14.06
-0.83 (-5.57%)
Pre-market:Sep 20, 2021 9:04 AM EDT
14.89
0.45 (3.12%)
At close: Sep 17, 4:00 PM
Market Cap1.71B
Revenue (ttm)169.07M
Net Income (ttm)-5.70M
Shares Out114.63M
EPS (ttm)-0.10
PE Ration/a
Forward PE74.63
Dividendn/a
Ex-Dividend Daten/a
Volume2,771,956
Open14.57
Previous Close14.44
Day's Range14.26 - 15.09
52-Week Range3.58 - 20.40
Beta1.38
AnalystsStrong Buy
Price Target21.00 (+41.0%)
Est. Earnings DateNov 4, 2021

About DVAX

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd....

IndustryBiotechnology
IPO DateFeb 19, 2004
CEORyan Spencer
Employees245
Stock ExchangeNASDAQ
Ticker SymbolDVAX
Full Company Profile

Financial Performance

In 2020, DVAX's revenue was $46.55 million, an increase of 32.18% compared to the previous year's $35.22 million. Losses were -$75.24 million, -50.69% less than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for DVAX stock is "Strong Buy." The 12-month stock price forecast is 21.00, which is an increase of 41.03% from the latest price.

Price Target
$21.00
(41.03% upside)
Analyst Consensus: Strong Buy

News

5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch

Their vaccines could be late to the party. But the stocks might still be big winners.

Other symbols:GSKINONVAXSNY
2 days ago - The Motley Fool

Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine

Saint- Herb lain (Franc e ) , September 14 , 2021 – Valneva SE, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in Valneva's ...

6 days ago - GlobeNewsWire

Why Dynavax Technologies Stock Is Sinking Today

A lost supply agreement for a partner's COVID-19 vaccine is hurting the biotech's shares today.

6 days ago - The Motley Fool

Why Dynavax Shares Are Trading Lower Today

Dynavax Technologies Corp (NASDAQ: DVAX) is trading lower after the company announced Valneva SE (NASDAQ: VALN) received a termination notice from the United Kingdom government in relation to Valneva's ...

6 days ago - Benzinga

Dynavax Provides Update on its COVID-19 Collaboration with Valneva

EMERYVILLE, Calif., Sept. 13, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that V...

1 week ago - PRNewsWire

Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government

Saint- Herb lain (France ) , September 13 , 2021 – Valneva SE, a specialty vaccine company, today announced that it has received a termination notice from the UK Government (“HMG”) in relation to the Su...

1 week ago - GlobeNewsWire

Dynavax to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

EMERYVILLE, Calif., Sept. 9, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ry...

1 week ago - PRNewsWire

Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., Sept. 2, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 224,000 shares...

2 weeks ago - PRNewsWire

Why Dynavax Stock Is Skyrocketing 45.8% This Week

One of the company's partners launched its COVID-19 vaccine in Taiwan.

3 weeks ago - The Motley Fool

Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine

Dynavax (DVAX) stock gains as partner Medigen announces launch of its COVID-19 vaccine MVC-COV1901 adjuvanted with CpG 1018 of the former.

3 weeks ago - Zacks Investment Research

Why Coronavirus Stock Dynavax Crushed It Today

There was some very good news on the authorization front for the company.

3 weeks ago - The Motley Fool

Powered By Dynavax Adjuvant, Medigen COVID-19 Vaccine Launched In Taiwan

Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation (NASDAQ: DVAX) announced the rollout of their COVID-19 vaccine, MVC-COV1901, in Taiwan.  Approximately 600,000 people are antic...

3 weeks ago - Benzinga

Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine MVC-COV1901 Adjuvanted with Dynavax's CpG 1018 Adj...

TAIPEI, Taiwan and EMERYVILLE, Calif., Aug. 23, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corporation (MVC) (TPEx: 6547.TWO), a biopharmaceutical company focusing on the development and production ...

4 weeks ago - PRNewsWire

Why Dynavax, Novavax, and Inovio Stocks Sank This Week

Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.

Other symbols:INONVAX
1 month ago - The Motley Fool

Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now

The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.

1 month ago - The Motley Fool

Why Dynavax, Novavax, and Sorrento Soared This Week

There were different reasons behind each of these COVID-19 vaccine stocks' big gains.

Other symbols:NVAXSRNE
1 month ago - The Motley Fool

Former Penny Stocks To Watch After Merck's (MRK) Latest FDA Win

Merck's FDA and coronavirus vaccine news sparked momentum in biotech stocks today. Here are 4 to watch.

Other symbols:GTBPIBBINOXLV
1 month ago - PennyStocks

Hot Biotech Stocks That Deserve Your Attention In August 2021

Is it time to add biotech stocks to your list this year? The post Hot Biotech Stocks That Deserve Your Attention In August 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...

Other symbols:AGENGTBP
1 month ago - PennyStocks

Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week

Each vaccine stock had its own separate catalyst.

Other symbols:BNTXMRNANVAX
1 month ago - The Motley Fool

Are Penny Stocks Worth It? 5 That Deserve Your Attention Now

Have penny stocks presented some of the biggest opportunities in the stock market? The post Are Penny Stocks Worth It?

Other symbols:GTBPNVAXPACBSAVA
1 month ago - PennyStocks

Dynavax Technologies (DVAX) Q2 Earnings and Revenues Top Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 150.00% and 19.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Dynavax Announces Second Quarter 2021 Financial Results

EMERYVILLE, Calif., Aug. 4, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today reported fin...

1 month ago - PRNewsWire

Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., Aug. 3, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 438,000 shares ...

1 month ago - PRNewsWire

Dynavax Technologies (DVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Dynavax Technologies (DVAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021

EMERYVILLE, Calif. , July 21, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report seco...

1 month ago - PRNewsWire